Rossari Biotech Limited — Investor Meet, 25-10-2024: Analysts/Institutional Investor Meet/Con. Call Updates

Rossari Biotech Limited reported steady performance in Q2 FY25, with revenues increasing by 3% to ₹498.4 crore. Growth stemmed from the HPPC division, while the Textile sector faced headwinds but remains optimistic for recovery. Exports grew by 32%, constituting 25% of total sales. The company announced expansion initiatives, including a new subsidiary in the UAE and investments in manufacturing capabilities. Key sustainability efforts were highlighted, and a new Independent Director was appointed to bolster expertise in innovation.